|
CA1247080A
(en)
|
1983-03-08 |
1988-12-20 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
NZ207394A
(en)
|
1983-03-08 |
1987-03-06 |
Commw Serum Lab Commission |
Detecting or determining sequence of amino acids
|
|
WO1984003506A1
(en)
|
1983-03-08 |
1984-09-13 |
Commw Serum Lab Commission |
Antigenically active amino acid sequences
|
|
US4863940A
(en)
*
|
1984-07-26 |
1989-09-05 |
Rohm And Haas |
N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
|
|
NZ215865A
(en)
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US5571689A
(en)
|
1988-06-16 |
1996-11-05 |
Washington University |
Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
WO1990007329A1
(en)
|
1989-01-06 |
1990-07-12 |
The Regents Of The University Of California |
Selection method for pharmacologically active compounds
|
|
EP0594600A1
(en)
|
1990-03-13 |
1994-05-04 |
FISONS plc |
Immunosuppressive macrocyclic compounds
|
|
AU668347B2
(en)
|
1990-11-21 |
1996-05-02 |
Torrey Pines Institute For Molecular Studies |
Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
WO1992013549A1
(en)
|
1991-02-07 |
1992-08-20 |
Research Corporation Technologies, Inc. |
Inhibition of cell proliferation by hydrophobic peptides
|
|
SE9102462D0
(sv)
|
1991-08-28 |
1991-08-28 |
Astra Ab |
New isosteric peptides
|
|
DE59206778D1
(de)
|
1991-10-07 |
1996-08-22 |
Hoechst Ag |
Verfahren zur diastereoselektiven reduktiven Pinakol-Kupplung von homochiralen alpha-Aminoaldehyden
|
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
|
EP0650368A1
(en)
|
1992-06-24 |
1995-05-03 |
Cortex Pharmaceuticals, Inc. |
Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
|
|
US5658885A
(en)
|
1993-04-27 |
1997-08-19 |
The Dupont Merck Pharmaceutical Company |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
|
|
WO1995009859A1
(en)
|
1993-10-07 |
1995-04-13 |
The Du Pont Merck Pharmaceutical Company |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
|
ATE377006T1
(de)
|
1995-11-28 |
2007-11-15 |
Cephalon Inc |
Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
|
|
DE19642591A1
(de)
|
1996-10-15 |
1998-04-16 |
Basf Ag |
Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
|
|
AU7179598A
(en)
|
1996-11-13 |
1998-06-03 |
Cephalon, Inc. |
Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
|
|
DE19648793A1
(de)
|
1996-11-26 |
1998-05-28 |
Basf Ag |
Neue Benzamide und deren Anwendung
|
|
US5952322A
(en)
|
1996-12-05 |
1999-09-14 |
Pfizer Inc. |
Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
|
|
DE19650975A1
(de)
|
1996-12-09 |
1998-06-10 |
Basf Ag |
Neue heterocyclisch substituierte Benzamide und deren Anwendung
|
|
CN1245486A
(zh)
|
1996-12-11 |
2000-02-23 |
Basf公司 |
用作钙蛋白酶抑制剂的酮苯甲酰胺
|
|
JP4467648B2
(ja)
|
1997-03-14 |
2010-05-26 |
スミスクライン・ビーチャム・コーポレイション |
新規インドールカルボキサミド、医薬組成物およびカルパインの阻害方法
|
|
EP1491533A3
(en)
|
1997-03-14 |
2005-01-19 |
Cephalon, Inc. |
Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors
|
|
US6150378A
(en)
|
1997-10-07 |
2000-11-21 |
Cephalon, Inc. |
Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6083944A
(en)
|
1997-10-07 |
2000-07-04 |
Cephalon, Inc. |
Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
AU2960599A
(en)
|
1998-03-30 |
1999-10-18 |
Akira Karasawa |
Quinazoline derivatives
|
|
WO1999054310A2
(de)
|
1998-04-20 |
1999-10-28 |
Basf Aktiengesellschaft |
Neue substituierte amide, deren herstellung und anwendung
|
|
DE19817461A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Benzamide, deren Herstellung und Anwendung
|
|
DE19818614A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Amide, deren Herstellung und Anwendung
|
|
DE19817459A1
(de)
*
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue heterozyklische substituierte Amide, Herstellung und Anwendung
|
|
WO1999054320A1
(de)
|
1998-04-20 |
1999-10-28 |
Basf Aktiengesellschaft |
Neue heterocyclisch substituierte amide mit cystein-protease hemmender wirkung
|
|
WO1999054305A1
(de)
*
|
1998-04-20 |
1999-10-28 |
Basf Aktiengesellschaft |
Heterocyclisch substituierte amide als calpainhemmer
|
|
ATE524440T1
(de)
|
1998-05-25 |
2011-09-15 |
Abbott Gmbh & Co Kg |
Heterocyclische substituierte amide, deren herstellung und anwendung
|
|
US6335155B1
(en)
|
1998-06-26 |
2002-01-01 |
Sunesis Pharmaceuticals, Inc. |
Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
|
|
US6280946B2
(en)
|
1998-08-07 |
2001-08-28 |
Boston Probes, Inc. |
PNA probes, probe sets, methods and kits pertaining to the universal detection of bacteria and eucarya
|
|
CA2355215A1
(en)
|
1998-12-28 |
2000-07-06 |
Jim Wells |
Identifying small organic molecule ligands for binding
|
|
DE60021254T2
(de)
*
|
1999-03-15 |
2006-04-20 |
AXYS Pharmaceuticals, Inc., South San Francisco |
N-cyanomethylamide als protease inhibitoren
|
|
HK1039110A1
(zh)
|
1999-03-15 |
2002-04-12 |
Axys Pharmaceuticals, Inc. |
以新颖的合成物及组分作为蛋白酶抑制剂
|
|
AU3876600A
(en)
|
1999-03-16 |
2000-10-04 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
|
DK1194425T3
(da)
|
1999-06-23 |
2005-11-21 |
Aventis Pharma Gmbh |
Substituerede benzimidazoler
|
|
AU2001228811A1
(en)
|
2000-01-26 |
2001-08-07 |
Ono Pharmaceutical Co. Ltd. |
Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
|
|
WO2001089584A2
(en)
|
2000-05-23 |
2001-11-29 |
Amersham Health As |
Contrast agents
|
|
US6582827B1
(en)
|
2000-11-27 |
2003-06-24 |
The Trustees Of Columbia University In The City Of New York |
Specialized substrates for use in sequential lateral solidification processing
|
|
DE10114762A1
(de)
|
2001-03-26 |
2002-10-02 |
Knoll Gmbh |
Verwendung von Cysteinprotease-Inhibitoren
|
|
DK2280070T3
(en)
|
2001-07-23 |
2015-08-24 |
Univ Leland Stanford Junior |
Methods and compositions for use in RNAi-mediated inhibition of gene expression in mammals
|
|
WO2003024955A2
(en)
|
2001-09-18 |
2003-03-27 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
US20030167490A1
(en)
|
2001-11-26 |
2003-09-04 |
Hunter Craig P. |
Gene silencing by systemic RNA interference
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
KR20040096541A
(ko)
|
2002-01-31 |
2004-11-16 |
모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 |
인자 Ｘａ 활성을 저해하는 화합물
|
|
NZ536728A
(en)
|
2002-04-25 |
2006-07-28 |
Ono Pharmaceutical Co |
Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
|
|
AU2003265398A1
(en)
|
2002-08-09 |
2004-02-25 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
|
KR101076018B1
(ko)
|
2003-01-08 |
2011-10-21 |
유니버시티 오브 워싱톤 |
항균제
|
|
US20040242542A1
(en)
|
2003-03-25 |
2004-12-02 |
The Regents Of The University Of California |
Compositions and methods for inducing CD81 dependent antiproliferation and for treating hepatitis C and other disorders
|
|
WO2005000793A1
(ja)
|
2003-06-26 |
2005-01-06 |
Taisho Pharmaceutical Co., Ltd. |
２位置換シクロアルキルカルボン酸誘導体
|
|
EP1493739A1
(fr)
|
2003-07-03 |
2005-01-05 |
Warner-Lambert Company LLC |
Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
CA2532948A1
(en)
|
2003-07-21 |
2005-02-17 |
Novartis Ag |
Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
CA2535337A1
(en)
|
2003-08-14 |
2005-03-03 |
Merck & Co., Inc. |
Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
WO2005102381A1
(ja)
|
2004-04-26 |
2005-11-03 |
Ono Pharmaceutical Co., Ltd. |
カテプシンｋ阻害薬およびpth類を併用することを特徴とする骨密度増加剤
|
|
SG155229A1
(en)
|
2004-11-09 |
2009-09-30 |
Smithkline Beecham Corp |
Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
|
|
CA2619153C
(en)
|
2005-01-21 |
2013-12-31 |
President And Fellows Of Harvard College |
Regulation of protein synthesis by inhibition of eif4e-eif4g interaction
|
|
WO2006122237A2
(en)
|
2005-05-11 |
2006-11-16 |
University Of Florida Research Foundation, Inc. |
Imaging of neural and organ injury or damage
|
|
EP1915382A2
(en)
|
2005-08-01 |
2008-04-30 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
WO2007076423A2
(en)
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
|
WO2007081530A2
(en)
|
2006-01-03 |
2007-07-19 |
Med Institute, Inc. |
Endoluminal medical device for local delivery of cathepsin inhibitors
|
|
EP2029153A2
(en)
|
2006-01-27 |
2009-03-04 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
US20070207144A1
(en)
|
2006-02-16 |
2007-09-06 |
Lee Rubin |
Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
|
|
EP1993994A2
(en)
|
2006-03-16 |
2008-11-26 |
Vertex Pharmceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
|
JP2009539815A
(ja)
|
2006-06-09 |
2009-11-19 |
アストラゼネカ アクチボラグ |
固形腫瘍の治療用のａ５ｂ１アンタゴニストとしてのＮ−（ベンゾイル）−Ｏ−［２−（ピリジン−２−イルアミノ）エチル］−Ｌ−チロシン誘導体と関連化合物
|
|
WO2008048121A2
(en)
|
2006-10-18 |
2008-04-24 |
Lincoln University |
Macrocyclic cysteine protease inhibitors and compositions thereof
|
|
AR064693A1
(es)
*
|
2006-12-29 |
2009-04-22 |
Abbott Gmbh & Co Kg |
Compuestos carboxamidas y su utilizacion en la elaboracion de un medicamento para el tratamiento de enfermedades asociadas a alta actividad de calpaina.
|
|
JP2010519329A
(ja)
|
2007-02-27 |
2010-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ阻害剤
|
|
TWI519508B
(zh)
|
2007-06-12 |
2016-02-01 |
Achaogen Inc |
抗菌劑
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
TWI453019B
(zh)
|
2007-12-28 |
2014-09-21 |
Abbvie Deutschland |
甲醯胺化合物
|
|
TW201010700A
(en)
|
2008-08-25 |
2010-03-16 |
Piramal Lifesciences Ltd |
Diacylglycerol acyltransferase inhibitors
|
|
US8629157B2
(en)
|
2009-01-05 |
2014-01-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolidine compounds which modulate the CB2 receptor
|
|
GB2467561A
(en)
|
2009-02-06 |
2010-08-11 |
Summit Corp Plc |
Dual calpain-ROS inhibitors
|
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途
|
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
|
US8598211B2
(en)
|
2009-12-22 |
2013-12-03 |
Abbvie Inc. |
Carboxamide compounds and their use as calpain inhibitors IV
|
|
US9051304B2
(en)
|
2009-12-22 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
JP2013516422A
(ja)
|
2009-12-30 |
2013-05-13 |
アビラ セラピューティクス， インコーポレイテッド |
タンパク質のリガンド−指向性共有的修飾
|
|
EP2560491A1
(en)
|
2010-04-21 |
2013-02-27 |
Signature Therapeutics, Inc. |
Peripheral opioid agonists and peripheral opioid antagonists
|
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
|
WO2011159781A2
(en)
|
2010-06-17 |
2011-12-22 |
Senomyx, Inc. |
Bitter taste modulators
|
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
|
WO2012021788A2
(en)
|
2010-08-13 |
2012-02-16 |
Banyan Biomarkers |
Dipeptide calpain inhibitors
|
|
EP2606031B1
(en)
|
2010-08-20 |
2017-09-27 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
|
US20120095211A1
(en)
|
2010-09-22 |
2012-04-19 |
Intermune, Inc. |
Substituted proline inhibitors of hepatitis c virus replication
|
|
JP2013544866A
(ja)
|
2010-12-09 |
2013-12-19 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
カルボキサミド化合物及びカルパイン阻害剤ｖとしてのその使用
|
|
JP6148182B2
(ja)
|
2011-03-09 |
2017-06-14 |
シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. |
複素環式リンカーを有する活性薬剤プロドラッグ
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
DK2697246T3
(en)
|
2011-04-15 |
2018-05-28 |
Genesis Tech Limited |
SELECTIVE CYSTEIN PROTEASE INHIBITORS AND USES THEREOF
|
|
PL2753334T3
(pl)
|
2011-08-30 |
2022-12-12 |
Trustees Of Tufts College |
Aktywowane przez fap inhibitory proteasomu do leczenia guzów litych
|
|
CA2854569A1
(en)
|
2011-11-25 |
2013-05-30 |
David Banner |
Novel pyrrolidine derivatives as inhibitors of cathepsin
|
|
CA2852173A1
(en)
|
2012-01-11 |
2013-07-18 |
Lilli Anselm |
Macrocyclic amides as protease inhibitors
|
|
SG11201406345XA
(en)
*
|
2012-04-03 |
2014-11-27 |
Abbvie Deutschland |
Carboxamide compounds and their use as calpain inhibitors v
|
|
EP2844249A4
(en)
|
2012-05-02 |
2016-03-09 |
Univ Kansas State |
MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS VIRUZIDES AGAINST 3C OR 3C LIKE PROTEASES OF PICORNIVERS, CALICIVIRES AND CORONA VIRUSES
|
|
JP2016501848A
(ja)
|
2012-11-16 |
2016-01-21 |
アデレード リサーチ アンド イノヴェーション プロプライエタリー リミテッド |
大環状化合物及びその使用
|
|
AR096788A1
(es)
|
2013-07-02 |
2016-02-03 |
Bristol Myers Squibb Co |
Compuestos tricíclicos de carboxamida como inhibidores potentes de rock
|
|
TW201605859A
(zh)
|
2013-11-14 |
2016-02-16 |
必治妥美雅史谷比公司 |
作為酪蛋白激酶１δ／ε抑制劑之新穎經取代之吡唑并－哌
|
|
JP2017517475A
(ja)
|
2014-02-19 |
2017-06-29 |
エーテーハー チューリヒ |
化合物ライブラリーの製造方法
|
|
CN106715426A
(zh)
*
|
2014-03-21 |
2017-05-24 |
拜耳医药股份有限公司 |
氰基取代的咪唑并[1,2‑a]吡啶甲酰胺及其用途
|
|
WO2015179441A2
(en)
|
2014-05-20 |
2015-11-26 |
Rqx Pharmaceuticals, Inc. |
Macrocyclic broad spectrum antibiotics
|
|
US20150368213A1
(en)
|
2014-06-20 |
2015-12-24 |
The University of Montana, Missoula, MT |
Novel Inhibitors of System Xc-
|
|
WO2016027284A2
(en)
|
2014-08-22 |
2016-02-25 |
Alkem Laboratories Ltd. |
Piperidine ureas as cathepsin cysteine protease inhibitors
|
|
ES2714283T3
(es)
|
2014-09-04 |
2019-05-28 |
Bristol Myers Squibb Co |
Macrociclos de diamida que son inhibidores de FXIa
|
|
WO2016037157A2
(en)
|
2014-09-05 |
2016-03-10 |
The Johns Hopkins University |
Targeting capn9/capns2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
|
|
WO2016089648A1
(en)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
|
|
AU2016287568B2
(en)
|
2015-07-02 |
2020-08-20 |
Turning Point Therapeutics, Inc. |
Chiral diaryl macrocycles as modulators of protein kinases
|
|
MX2018006856A
(es)
*
|
2015-12-07 |
2018-08-01 |
Plexxikon Inc |
Compuestos y metodos para modulacion de la quinasa, e indicaciones de los mismos.
|
|
CN105669520B
(zh)
|
2016-01-12 |
2018-10-30 |
山东大学 |
含有色氨酸基本骨架的邻苯二胺类选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
WO2017156074A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Calpain modulators and methods of production and use thereof
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
KR102519948B1
(ko)
|
2016-06-29 |
2023-04-11 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
암 치료용 화합물 및 조성물
|
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
WO2018064119A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
CA3067063A1
(en)
|
2017-06-23 |
2018-12-27 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
CA3093749A1
(en)
|
2018-03-28 |
2019-10-03 |
Blade Therapeutics, Inc. |
Method of treating fibrotic disease
|
|
RU2020130022A
(ru)
|
2018-03-28 |
2022-05-04 |
Блэйд Терапьютикс, Инк. |
Модуляторы кальпаина и их терапевтическое применение
|
|
WO2019217465A1
(en)
|
2018-05-09 |
2019-11-14 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof background
|
|
BR112020026744A2
(pt)
|
2018-06-28 |
2021-03-30 |
Blade Therapeutics, Inc. |
Métodos para tratar fibrose hepática com o uso de inibidores de calpaína
|
|
US20210238192A1
(en)
|
2018-06-29 |
2021-08-05 |
Blade Therapeutics, Inc. |
Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
|